Synopsys Could Be Set Up To Surprise Investors On August 26th

Photo of Joel South
By Joel South Published

Quick Read

  • SNPS beat EPS by ~6% in two consecutive quarters, raised full-year guidance, and carries an $11 billion backlog into its August 26 Q3 report.

  • SNPS grew Q2 revenue 42% versus CDNS's 24%, yet Cadence commands a roughly $10 billion larger market cap despite slower growth on a smaller revenue base.

  • Synopsys repaid $3.46 billion in debt during H1 and targets $2 billion in free cash flow, largely neutralizing the Ansys leverage concern bears cite.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Synopsys didn't make the cut. Grab the names FREE today.

Synopsys Could Be Set Up To Surprise Investors On August 26th

© gorodenkoff / iStock via Getty Images

Synopsys (NASDAQ:SNPS | SNPS Price Prediction) is the highest-conviction EDA setup in front of the August 26, 2026 after-market fiscal Q3 report, and the data behind that call leaves little room for deliberation. Two consecutive beat-and-raise quarters, expanding margins, and a rapidly deleveraging balance sheet frame the risk/reward as one-sided.

SNPS price target

Beat-And-Raise Pattern Already In Motion

Synopsys posted non-GAAP EPS of $3.35 against a $3.1617 consensus in Q2, a 5.96% beat, on the heels of a 5.98% Q1 beat. Revenue climbed 41.98% year-over-year to $2.28 billion. Management then raised the FY2026 non-GAAP EPS range to $14.72 to $14.80 and revenue to $9,625 to $9,705 million. Q3 guidance already calls for revenue of $2,410 to $2,460 million and EPS of $3.63 to $3.69. The trajectory is a company beating its own raised bar.

SNPS earnings explorer

AI-Driven EDA Demand Is Compounding

Design Automation adjusted operating margin expanded to 43.3%, and backlog reached $11 billion. CEO Sassine Ghazi framed demand directly: “AI is scaling semiconductor demand, architectural diversity and complexity of chips and the systems they power”. Hyperscaler custom silicon and Ansys integration synergies drove more than 30 full-flow technical wins in Q2 alone.

Cash Generation Funds The Deleveraging

Synopsys targets approximately $2,000 million in FY2026 free cash flow and repaid $3.46 billion in debt during H1 FY2026, alongside $262.5 million in buybacks. The September 30, 2026 Investor Day extends the story past this report.

Head-To-Head Against Cadence

Cadence Design Systems (NASDAQ:CDNS) is the obvious comparable, and it loses on the metrics that matter. Cadence grew Q2 revenue 24.23% year-over-year against Synopsys’s 41.98%. Cadence’s FY2026 non-GAAP EPS guide of $8.05 to $8.15 and revenue guide of $6.26 billion to $6.34 billion sit well below Synopsys’s $14.76 EPS midpoint and $9,665 million revenue midpoint. Cadence carries a larger $86.74 billion market cap versus SNPS at roughly $76.83 billion. Investors are paying more for slower growth on a smaller revenue base.

CDNS price target

Dismissing The Debt Concern

The standard pushback centers on the $10.0 billion long-term debt load from the Ansys deal and $403.6 million of quarterly intangibles amortization pressuring GAAP earnings. That objection collapses under H1’s $3.46 billion in paydown and roughly $2B in annual free cash flow, and amortization is a non-cash accounting item. Analyst positioning agrees, at 18 buy, 5 hold, and 1 sell, with an average target of $561.03 against a recent print of $401.24.

SNPS analyst ratings

SNPS sits at the top of the pre-earnings watchlist heading into next Wednesday’s release.

Contact [email protected] for any questions or corrections.

Photo of Joel South
About the Author Joel South →

Joel South covers large-cap stocks, dividend investing, and major market trends, with a focus on earnings analysis, valuation, and turning complex data into actionable insights for investors.

He brings more than 15 years of experience as an investor and financial journalist, including 12 years at The Motley Fool, where he served as an investment analyst, Bureau Chief, and later led the Fool.com investing news desk. He has also co-hosted an investing podcast and appeared across TV and radio discussing market trends.

Continue Reading

Top Gaining Stocks

MRNA Vol: 86,561,177
COIN Vol: 21,402,740
FCX Vol: 27,053,197
ALB Vol: 3,180,718
EL Vol: 5,643,251

Top Losing Stocks

CTRA Vol: 73,319,495
SRE Vol: 3,785,082
EIX Vol: 3,937,069
AEP Vol: 5,244,401
CNP Vol: 7,815,268